Statistics
Player Statistics
Every FPL player — points, price, form, ownership and upcoming fixtures. Filter by team and position.
564 players
Name | Fixtures | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| £15.5m | 75.3% | 239 | 0.0 | 15.4 | 0 | 27 | 8 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £12.0m | 48.8% | 235 | 0.0 | 19.6 | 0 | 9 | 24 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £8.0m | 25.4% | 209 | 0.0 | 26.1 | 0 | 3 | 5 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £8.5m | 20.6% | 202 | 0.0 | 23.8 | 0 | 17 | 6 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £8.0m | 12.3% | 188 | 0.0 | 23.5 | 0 | 15 | 4 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £7.5m | 22.1% | 184 | 0.0 | 24.5 | 0 | 4 | 9 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £8.0m | 15.9% | 181 | 0.0 | 22.6 | 0 | 22 | 1 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £6.5m | 12.0% | 180 | 0.0 | 27.7 | 0 | 4 | 5 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £6.0m | 24.3% | 179 | 0.0 | 29.8 | 0 | 3 | 5 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £7.5m | 53.8% | 177 | 0.0 | 23.6 | 0 | 15 | 9 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.5m | 16.0% | 175 | 0.0 | 26.9 | 0 | 6 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.0m | 11.1% | 175 | 0.0 | 29.2 | 0 | 0 | 6 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.0m | 9.8% | 170 | 0.0 | 28.3 | 0 | 2 | 3 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £7.5m | 32.5% | 169 | 0.0 | 22.5 | 0 | 10 | 8 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.5m | 8.9% | 168 | 0.0 | 25.8 | 0 | 10 | 9 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £8.0m | 12.2% | 167 | 0.0 | 20.9 | 0 | 16 | 4 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 4.6% | 165 | 0.0 | 30.0 | 0 | 1 | 6 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.0m | 30.3% | 162 | 0.0 | 27.0 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £7.0m | 48.1% | 160 | 0.0 | 22.9 | 0 | 6 | 7 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.5m | 23.5% | 160 | 0.0 | 24.6 | 0 | 5 | 4 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £6.0m | 1.2% | 159 | 0.0 | 26.5 | 0 | 2 | 7 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £9.5m | 10.7% | 157 | 0.0 | 16.5 | 0 | 7 | 10 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £7.0m | 5.3% | 157 | 0.0 | 22.4 | 0 | 10 | 5 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.0m | 11.9% | 154 | 0.0 | 25.7 | 0 | 1 | 2 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £6.0m | 5.3% | 154 | 0.0 | 25.7 | 0 | 1 | 8 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £7.0m | 8.0% | 154 | 0.0 | 22.0 | 0 | 9 | 7 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.5m | 4.1% | 151 | 0.0 | 23.2 | 0 | 8 | 7 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 7.7% | 151 | 0.0 | 27.5 | 0 | 3 | 5 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.5m | 0.6% | 149 | 0.0 | 22.9 | 0 | 3 | 6 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £8.0m | 13.6% | 148 | 0.0 | 18.5 | 0 | 11 | 3 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 8.1% | 148 | 0.0 | 29.6 | 0 | 3 | 3 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.0m | 10.9% | 147 | 0.0 | 24.5 | 0 | 5 | 6 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.0m | 1.9% | 144 | 0.0 | 24.0 | 0 | 5 | 5 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 5.5% | 143 | 0.0 | 28.6 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £8.0m | 15.3% | 143 | 0.0 | 17.9 | 0 | 10 | 4 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £6.0m | 17.9% | 142 | 0.0 | 23.7 | 0 | 14 | 2 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 0.5% | 137 | 0.0 | 22.8 | 0 | 1 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £6.0m | 1.5% | 137 | 0.0 | 22.8 | 0 | 7 | 4 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.0m | 1.4% | 137 | 0.0 | 22.8 | 0 | 5 | 6 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 1.6% | 136 | 0.0 | 22.7 | 0 | 3 | 2 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.5m | 1.4% | 136 | 0.0 | 20.9 | 0 | 7 | 8 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 2.1% | 136 | 0.0 | 24.7 | 0 | 3 | 1 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.5m | 12.1% | 136 | 0.0 | 24.7 | 0 | 4 | 4 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 5.6% | 136 | 0.0 | 27.2 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 7.2% | 135 | 0.0 | 30.0 | 0 | 1 | 3 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.5m | 8.9% | 135 | 0.0 | 24.5 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 11.2% | 135 | 0.0 | 24.5 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £7.5m | 9.6% | 135 | 0.0 | 18.0 | 0 | 4 | 13 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £6.0m | 4.3% | 135 | 0.0 | 22.5 | 0 | 3 | 4 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 1.3% | 134 | 0.0 | 24.4 | 0 | 1 | 4 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.5m | 1.5% | 133 | 0.0 | 24.2 | 0 | 5 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 3.0% | 131 | 0.0 | 26.2 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 1.5% | 131 | 0.0 | 26.2 | 0 | 3 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £7.0m | 3.4% | 131 | 0.0 | 18.7 | 0 | 7 | 5 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £7.0m | 7.1% | 131 | 0.0 | 18.7 | 0 | 7 | 5 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 16.8% | 130 | 0.0 | 28.9 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 2.0% | 129 | 0.0 | 23.5 | 0 | 1 | 2 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £7.5m | 13.3% | 128 | 0.0 | 17.1 | 0 | 14 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.8% | 128 | 0.0 | 25.6 | 0 | 1 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £6.0m | 19.0% | 128 | 0.0 | 21.3 | 0 | 6 | 3 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.0m | 13.4% | 128 | 0.0 | 25.6 | 0 | 2 | 3 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £6.0m | 2.9% | 126 | 0.0 | 21.0 | 0 | 13 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.6% | 126 | 0.0 | 22.9 | 0 | 4 | 8 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 2.4% | 126 | 0.0 | 25.2 | 0 | 4 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.0m | 2.4% | 125 | 0.0 | 20.8 | 0 | 8 | 5 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £6.5m | 1.2% | 125 | 0.0 | 19.2 | 0 | 5 | 7 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £7.5m | 10.6% | 125 | 0.0 | 16.7 | 0 | 5 | 4 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £7.5m | 0.2% | 125 | 0.0 | 16.7 | 0 | 11 | 4 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 1.2% | 125 | 0.0 | 25.0 | 0 | 1 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 3.5% | 124 | 0.0 | 27.6 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.5m | 6.2% | 124 | 0.0 | 22.5 | 0 | 1 | 6 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.0m | 0.1% | 123 | 0.0 | 24.6 | 0 | 0 | 1 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.5m | 3.2% | 122 | 0.0 | 27.1 | 0 | 0 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.0m | 4.4% | 120 | 0.0 | 24.0 | 0 | 0 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £7.5m | 6.4% | 120 | 0.0 | 16.0 | 0 | 5 | 8 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.5m | 2.2% | 119 | 0.0 | 21.6 | 0 | 0 | 1 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £6.0m | 1.6% | 119 | 0.0 | 19.8 | 0 | 11 | 4 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 3.1% | 118 | 0.0 | 26.2 | 0 | 1 | 2 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 7.9% | 117 | 0.0 | 26.0 | 0 | 3 | 3 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £6.0m | 0.7% | 117 | 0.0 | 19.5 | 0 | 3 | 8 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £6.5m | 11.1% | 117 | 0.0 | 18.0 | 0 | 9 | 2 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.5m | 24.0% | 117 | 0.0 | 21.3 | 0 | 1 | 3 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.5% | 116 | 0.0 | 23.2 | 0 | 1 | 3 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.0m | 6.3% | 116 | 0.0 | 23.2 | 0 | 4 | 1 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 3.0% | 116 | 0.0 | 23.2 | 0 | 2 | 2 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.0m | 1.9% | 115 | 0.0 | 19.2 | 0 | 6 | 7 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.5m | 0.5% | 115 | 0.0 | 20.9 | 0 | 3 | 4 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 8.1% | 115 | 0.0 | 20.9 | 0 | 2 | 6 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £9.5m | 13.2% | 114 | 0.0 | 12.0 | 0 | 10 | 2 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.5m | 7.3% | 114 | 0.0 | 17.5 | 0 | 12 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £6.0m | 4.5% | 114 | 0.0 | 19.0 | 0 | 6 | 6 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £6.5m | 3.3% | 113 | 0.0 | 17.4 | 0 | 7 | 3 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £7.5m | 9.8% | 113 | 0.0 | 15.1 | 0 | 13 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.7% | 113 | 0.0 | 22.6 | 0 | 0 | 3 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 4.5% | 113 | 0.0 | 25.1 | 0 | 1 | 2 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 0.7% | 113 | 0.0 | 20.5 | 0 | 4 | 4 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 2.0% | 113 | 0.0 | 22.6 | 0 | 0 | 1 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.5m | 1.4% | 113 | 0.0 | 20.5 | 0 | 2 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 23.9% | 113 | 0.0 | 25.1 | 0 | 1 | 1 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.5m | 0.2% | 112 | 0.0 | 20.4 | 0 | 1 | 6 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 3.2% | 111 | 0.0 | 22.2 | 0 | 1 | 6 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £7.0m | 3.1% | 111 | 0.0 | 15.9 | 0 | 11 | 2 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.5m | 1.4% | 110 | 0.0 | 20.0 | 0 | 0 | 3 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.5m | 3.8% | 110 | 0.0 | 20.0 | 0 | 3 | 1 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 1.4% | 110 | 0.0 | 24.4 | 0 | 2 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.5m | 14.1% | 109 | 0.0 | 19.8 | 0 | 1 | 2 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.5m | 2.0% | 109 | 0.0 | 24.2 | 0 | 2 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 0.8% | 109 | 0.0 | 18.2 | 0 | 8 | 3 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 20.0% | 109 | 0.0 | 21.8 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.5% | 108 | 0.0 | 21.6 | 0 | 0 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 1.9% | 108 | 0.0 | 19.6 | 0 | 2 | 5 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.0m | 1.6% | 108 | 0.0 | 18.0 | 0 | 8 | 4 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.0m | 1.2% | 106 | 0.0 | 17.7 | 0 | 7 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 1.4% | 105 | 0.0 | 21.0 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 1.5% | 104 | 0.0 | 20.8 | 0 | 1 | 3 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 3.3% | 104 | 0.0 | 18.9 | 0 | 9 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 2.7% | 103 | 0.0 | 18.7 | 0 | 5 | 4 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 0.5% | 103 | 0.0 | 22.9 | 0 | 1 | 1 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 0.9% | 103 | 0.0 | 18.7 | 0 | 4 | 3 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £6.0m | 0.8% | 102 | 0.0 | 17.0 | 0 | 6 | 2 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 18.2% | 100 | 0.0 | 22.2 | 0 | 0 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 0.7% | 100 | 0.0 | 22.2 | 0 | 1 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.3% | 99 | 0.0 | 19.8 | 0 | 1 | 3 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.5m | 0.1% | 98 | 0.0 | 17.8 | 0 | 3 | 2 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 0.6% | 98 | 0.0 | 17.8 | 0 | 3 | 4 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 1.3% | 97 | 0.0 | 21.6 | 0 | 0 | 7 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 2.0% | 97 | 0.0 | 19.4 | 0 | 5 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 1.2% | 96 | 0.0 | 19.2 | 0 | 2 | 3 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.4% | 96 | 0.0 | 21.3 | 0 | 1 | 5 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 1.1% | 96 | 0.0 | 19.2 | 0 | 0 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.0m | 24.9% | 96 | 0.0 | 24.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 1.4% | 95 | 0.0 | 21.1 | 0 | 0 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 0.9% | 95 | 0.0 | 17.3 | 0 | 8 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.4% | 95 | 0.0 | 21.1 | 0 | 3 | 3 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £6.0m | 2.0% | 95 | 0.0 | 15.8 | 0 | 4 | 4 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.3% | 94 | 0.0 | 18.8 | 0 | 2 | 4 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.5% | 94 | 0.0 | 20.9 | 0 | 2 | 1 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 2.7% | 93 | 0.0 | 18.6 | 0 | 1 | 3 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.0m | 0.4% | 92 | 0.0 | 15.3 | 0 | 5 | 3 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £6.0m | 22.4% | 92 | 0.0 | 15.3 | 0 | 7 | 2 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.0m | 0.3% | 91 | 0.0 | 15.2 | 0 | 4 | 5 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.4% | 91 | 0.0 | 18.2 | 0 | 0 | 3 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 4.1% | 91 | 0.0 | 16.5 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.0m | 1.5% | 91 | 0.0 | 15.2 | 0 | 2 | 5 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 1.0% | 91 | 0.0 | 18.2 | 0 | 4 | 1 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 7.0% | 90 | 0.0 | 18.0 | 0 | 1 | 2 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 1.6% | 90 | 0.0 | 20.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.4% | 89 | 0.0 | 17.8 | 0 | 1 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 0.4% | 89 | 0.0 | 17.8 | 0 | 2 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £6.0m | 0.0% | 88 | 0.0 | 14.7 | 0 | 3 | 4 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 4.8% | 87 | 0.0 | 15.8 | 0 | 1 | 2 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.5m | 0.8% | 87 | 0.0 | 15.8 | 0 | 3 | 5 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.1% | 86 | 0.0 | 15.6 | 0 | 1 | 1 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 0.3% | 85 | 0.0 | 15.5 | 0 | 1 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 6.1% | 85 | 0.0 | 15.5 | 0 | 2 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.5m | 1.6% | 84 | 0.0 | 18.7 | 0 | 2 | 3 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.2% | 83 | 0.0 | 15.1 | 0 | 1 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.2% | 83 | 0.0 | 15.1 | 0 | 4 | 2 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.0m | 0.2% | 82 | 0.0 | 13.7 | 0 | 3 | 2 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.5m | 0.2% | 82 | 0.0 | 14.9 | 0 | 1 | 7 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.5m | 0.2% | 81 | 0.0 | 18.0 | 0 | 1 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 0.1% | 81 | 0.0 | 14.7 | 0 | 1 | 3 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.5m | 3.0% | 81 | 0.0 | 14.7 | 0 | 0 | 2 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 0.4% | 80 | 0.0 | 14.5 | 0 | 3 | 1 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £6.0m | 0.0% | 80 | 0.0 | 13.3 | 0 | 2 | 5 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.4% | 80 | 0.0 | 16.0 | 0 | 0 | 2 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.5m | 0.3% | 79 | 0.0 | 12.2 | 0 | 2 | 6 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.5m | 8.6% | 79 | 0.0 | 14.4 | 0 | 2 | 2 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 4.4% | 79 | 0.0 | 15.8 | 0 | 1 | 2 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.5m | 3.8% | 78 | 0.0 | 14.2 | 0 | 1 | 6 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 10.2% | 78 | 0.0 | 17.3 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.0m | 0.3% | 78 | 0.0 | 13.0 | 0 | 4 | 2 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.7% | 77 | 0.0 | 15.4 | 0 | 2 | 2 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.5m | 0.2% | 77 | 0.0 | 14.0 | 0 | 2 | 2 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.0% | 76 | 0.0 | 15.2 | 0 | 2 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 0.7% | 76 | 0.0 | 16.9 | 0 | 0 | 2 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 0.1% | 76 | 0.0 | 15.2 | 0 | 1 | 3 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £6.0m | 2.1% | 76 | 0.0 | 12.7 | 0 | 7 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.0m | 0.6% | 75 | 0.0 | 12.5 | 0 | 4 | 1 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £6.5m | 0.3% | 75 | 0.0 | 11.5 | 0 | 2 | 6 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.5m | 3.0% | 74 | 0.0 | 11.4 | 0 | 1 | 7 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.1% | 74 | 0.0 | 14.8 | 0 | 1 | 4 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.5% | 74 | 0.0 | 16.4 | 0 | 0 | 2 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.5m | 1.3% | 74 | 0.0 | 13.5 | 0 | 6 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.5m | 0.6% | 73 | 0.0 | 13.3 | 0 | 6 | 1 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.5m | 1.3% | 73 | 0.0 | 13.3 | 0 | 1 | 2 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.5m | 0.0% | 73 | 0.0 | 13.3 | 0 | 2 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.5m | 0.4% | 72 | 0.0 | 11.1 | 0 | 3 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.5% | 72 | 0.0 | 14.4 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.5m | 0.0% | 72 | 0.0 | 13.1 | 0 | 1 | 4 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 0.1% | 71 | 0.0 | 15.8 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.4% | 71 | 0.0 | 14.2 | 0 | 2 | 4 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.1% | 69 | 0.0 | 13.8 | 0 | 0 | 5 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £6.5m | 0.1% | 69 | 0.0 | 10.6 | 0 | 1 | 1 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.1% | 68 | 0.0 | 13.6 | 0 | 0 | 3 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.5% | 68 | 0.0 | 15.1 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 0.9% | 68 | 0.0 | 11.3 | 0 | 0 | 4 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £6.0m | 1.3% | 67 | 0.0 | 11.2 | 0 | 4 | 3 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £6.5m | 3.4% | 67 | 0.0 | 10.3 | 0 | 5 | 2 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.2% | 67 | 0.0 | 13.4 | 0 | 3 | 2 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.3% | 67 | 0.0 | 13.4 | 0 | 0 | 2 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 67 | 0.0 | 13.4 | 0 | 1 | 4 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.0m | 0.3% | 67 | 0.0 | 13.4 | 0 | 2 | 1 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.5m | 2.0% | 67 | 0.0 | 12.2 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 4.9% | 67 | 0.0 | 14.9 | 0 | 0 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 0.0% | 65 | 0.0 | 13.0 | 0 | 0 | 2 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.0m | 0.2% | 65 | 0.0 | 10.8 | 0 | 2 | 1 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 3.2% | 65 | 0.0 | 14.4 | 0 | 1 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 0.1% | 65 | 0.0 | 11.8 | 0 | 2 | 6 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 0.2% | 64 | 0.0 | 14.2 | 0 | 0 | 2 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.1% | 63 | 0.0 | 11.5 | 0 | 1 | 3 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 3.0% | 63 | 0.0 | 11.5 | 0 | 0 | 5 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.5m | 0.1% | 63 | 0.0 | 11.5 | 0 | 1 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.2% | 63 | 0.0 | 12.6 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.0m | 0.3% | 62 | 0.0 | 10.3 | 0 | 3 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.5% | 62 | 0.0 | 12.4 | 0 | 2 | 3 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 0.1% | 61 | 0.0 | 12.2 | 0 | 1 | 3 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 0.2% | 61 | 0.0 | 13.6 | 0 | 0 | 2 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.0m | 0.2% | 61 | 0.0 | 12.2 | 0 | 2 | 2 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 0.9% | 60 | 0.0 | 10.9 | 0 | 0 | 2 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.2% | 59 | 0.0 | 11.8 | 0 | 1 | 3 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.1% | 59 | 0.0 | 11.8 | 0 | 0 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 0.1% | 58 | 0.0 | 12.9 | 0 | 0 | 2 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.5m | 1.4% | 58 | 0.0 | 8.9 | 0 | 2 | 5 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.5m | 0.1% | 58 | 0.0 | 10.5 | 0 | 3 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £6.5m | 0.3% | 57 | 0.0 | 8.8 | 0 | 1 | 5 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.2% | 56 | 0.0 | 11.2 | 0 | 3 | 2 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £6.0m | 1.1% | 56 | 0.0 | 9.3 | 0 | 1 | 4 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.6% | 56 | 0.0 | 11.2 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.2% | 56 | 0.0 | 11.2 | 0 | 2 | 2 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 0.0% | 56 | 0.0 | 11.2 | 0 | 0 | 4 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £7.0m | 0.6% | 56 | 0.0 | 8.0 | 0 | 3 | 3 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.6% | 56 | 0.0 | 11.2 | 0 | 0 | 1 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 1.7% | 55 | 0.0 | 12.2 | 0 | 1 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.6% | 54 | 0.0 | 12.0 | 0 | 0 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.1% | 53 | 0.0 | 9.6 | 0 | 0 | 3 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.8% | 53 | 0.0 | 11.8 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.1% | 53 | 0.0 | 10.6 | 0 | 1 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.5m | 0.2% | 52 | 0.0 | 11.6 | 0 | 0 | 2 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 0.9% | 51 | 0.0 | 10.2 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.1% | 51 | 0.0 | 10.2 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 0.2% | 50 | 0.0 | 11.1 | 0 | 0 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.7% | 50 | 0.0 | 9.1 | 0 | 1 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.1% | 49 | 0.0 | 8.9 | 0 | 1 | 3 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.5m | 0.2% | 49 | 0.0 | 8.9 | 0 | 1 | 3 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.0m | 0.7% | 48 | 0.0 | 8.0 | 0 | 0 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 0.1% | 48 | 0.0 | 9.6 | 0 | 1 | 1 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 0.1% | 47 | 0.0 | 9.4 | 0 | 2 | 1 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 1.5% | 47 | 0.0 | 9.4 | 0 | 1 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.2% | 46 | 0.0 | 9.2 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.5m | 0.0% | 46 | 0.0 | 8.4 | 0 | 0 | 2 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 0.0% | 45 | 0.0 | 8.2 | 0 | 0 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.5m | 0.5% | 45 | 0.0 | 8.2 | 0 | 1 | 2 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 10.6% | 45 | 0.0 | 10.0 | 0 | 0 | 1 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.5m | 0.0% | 44 | 0.0 | 8.0 | 0 | 1 | 3 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.2% | 44 | 0.0 | 8.0 | 0 | 1 | 1 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.7% | 43 | 0.0 | 9.6 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 1.6% | 43 | 0.0 | 7.2 | 0 | 2 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.5m | 0.1% | 43 | 0.0 | 6.6 | 0 | 1 | 2 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.0% | 43 | 0.0 | 8.6 | 0 | 1 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.5m | 0.4% | 43 | 0.0 | 7.8 | 0 | 4 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.5% | 42 | 0.0 | 7.6 | 0 | 0 | 2 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.0m | 0.0% | 42 | 0.0 | 8.4 | 0 | 0 | 2 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.5m | 0.4% | 42 | 0.0 | 9.3 | 0 | 0 | 1 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.5m | 0.7% | 42 | 0.0 | 7.6 | 0 | 2 | 1 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £6.0m | 0.9% | 41 | 0.0 | 6.8 | 0 | 2 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.0% | 41 | 0.0 | 8.2 | 0 | 2 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £9.0m | 11.4% | 41 | 0.0 | 4.6 | 0 | 3 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.0m | 1.8% | 41 | 0.0 | 6.8 | 0 | 3 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 17.4% | 40 | 0.0 | 7.3 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.1% | 40 | 0.0 | 8.0 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.1% | 40 | 0.0 | 8.0 | 0 | 0 | 1 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.0m | 2.9% | 40 | 0.0 | 6.7 | 0 | 3 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.1% | 39 | 0.0 | 8.7 | 0 | 0 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.2% | 39 | 0.0 | 8.7 | 0 | 1 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.0% | 39 | 0.0 | 8.7 | 0 | 0 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.5m | 0.0% | 39 | 0.0 | 8.7 | 0 | 2 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 0.0% | 38 | 0.0 | 7.6 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.1% | 38 | 0.0 | 7.6 | 0 | 0 | 2 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 0.1% | 37 | 0.0 | 8.2 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 0.2% | 37 | 0.0 | 6.7 | 0 | 2 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £7.5m | 4.0% | 36 | 0.0 | 4.8 | 0 | 2 | 3 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.0% | 36 | 0.0 | 7.2 | 0 | 1 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 36 | 0.0 | 7.2 | 0 | 1 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 0.7% | 36 | 0.0 | 6.5 | 0 | 1 | 1 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £5.0m | 0.1% | 36 | 0.0 | 7.2 | 0 | 1 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.5m | 0.3% | 35 | 0.0 | 6.4 | 0 | 2 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.1% | 34 | 0.0 | 7.6 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 0.2% | 34 | 0.0 | 6.8 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.3% | 34 | 0.0 | 6.8 | 0 | 1 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.0m | 0.1% | 33 | 0.0 | 6.6 | 0 | 0 | 2 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.5m | 2.0% | 32 | 0.0 | 5.8 | 0 | 1 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.0m | 0.1% | 32 | 0.0 | 6.4 | 0 | 0 | 3 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £4.0m | 20.5% | 31 | 0.0 | 7.8 | 0 | 1 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 7.6% | 30 | 0.0 | 6.7 | 0 | 0 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.3% | 29 | 0.0 | 5.3 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.5m | 0.2% | 29 | 0.0 | 6.4 | 0 | 0 | 1 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.1% | 29 | 0.0 | 5.8 | 0 | 0 | 1 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.4% | 29 | 0.0 | 6.4 | 0 | 0 | 1 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.5m | 0.2% | 27 | 0.0 | 4.9 | 0 | 1 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.0m | 1.4% | 27 | 0.0 | 4.5 | 0 | 1 | 1 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.5m | 0.0% | 26 | 0.0 | 4.7 | 0 | 0 | 2 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.0m | 2.3% | 26 | 0.0 | 6.5 | 0 | 0 | 1 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £6.0m | 0.1% | 25 | 0.0 | 4.2 | 0 | 0 | 2 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.0% | 25 | 0.0 | 5.6 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £6.0m | 0.4% | 24 | 0.0 | 4.0 | 0 | 3 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.5m | 0.0% | 23 | 0.0 | 4.2 | 0 | 2 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.4% | 23 | 0.0 | 4.2 | 0 | 2 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 23 | 0.0 | 4.6 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £4.5m | 0.1% | 22 | 0.0 | 4.9 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 0.1% | 21 | 0.0 | 3.8 | 0 | 0 | 2 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.1% | 21 | 0.0 | 4.2 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.1% | 20 | 0.0 | 4.4 | 0 | 0 | 1 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 17.3% | 20 | 0.0 | 4.4 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.1% | 19 | 0.0 | 3.8 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £4.5m | 1.4% | 19 | 0.0 | 4.2 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.2% | 19 | 0.0 | 4.2 | 0 | 0 | 1 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.5m | 0.1% | 18 | 0.0 | 3.3 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.0m | 0.0% | 17 | 0.0 | 3.4 | 0 | 0 | 1 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.5% | 17 | 0.0 | 3.4 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.5m | 0.1% | 17 | 0.0 | 3.1 | 0 | 0 | 1 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.1% | 16 | 0.0 | 2.9 | 0 | 1 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.5m | 0.1% | 16 | 0.0 | 3.6 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.5m | 0.1% | 16 | 0.0 | 2.9 | 0 | 1 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.1% | 16 | 0.0 | 2.9 | 0 | 1 | 1 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.1% | 16 | 0.0 | 2.9 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.1% | 16 | 0.0 | 3.6 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 1.1% | 15 | 0.0 | 3.3 | 0 | 1 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.5m | 0.1% | 14 | 0.0 | 3.1 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 0.0% | 14 | 0.0 | 2.8 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.5m | 0.0% | 13 | 0.0 | 2.4 | 0 | 0 | 1 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.0% | 13 | 0.0 | 2.6 | 0 | 1 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 0.0% | 13 | 0.0 | 2.6 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 0.5% | 13 | 0.0 | 2.6 | 0 | 0 | 1 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 1.5% | 13 | 0.0 | 2.6 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 0.7% | 13 | 0.0 | 2.9 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 0.1% | 13 | 0.0 | 2.6 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.0m | 0.2% | 12 | 0.0 | 2.4 | 0 | 0 | 2 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.0% | 12 | 0.0 | 2.4 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 0.0% | 12 | 0.0 | 2.4 | 0 | 0 | 1 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.2% | 11 | 0.0 | 2.2 | 0 | 0 | 1 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £4.5m | 0.2% | 11 | 0.0 | 2.4 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 0.1% | 11 | 0.0 | 2.4 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.5m | 0.0% | 11 | 0.0 | 2.4 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.5m | 0.0% | 10 | 0.0 | 2.2 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.0m | 0.7% | 10 | 0.0 | 2.5 | 0 | 1 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.1% | 9 | 0.0 | 1.8 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.5m | 0.0% | 9 | 0.0 | 1.6 | 0 | 0 | 1 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.5m | 0.1% | 9 | 0.0 | 1.6 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.5m | 0.0% | 8 | 0.0 | 1.5 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.0m | 0.0% | 8 | 0.0 | 1.6 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 2.0% | 8 | 0.0 | 1.6 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 0.1% | 7 | 0.0 | 1.4 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.5m | 0.0% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.1% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 0.1% | 6 | 0.0 | 1.3 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.0% | 6 | 0.0 | 1.3 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 8.6% | 6 | 0.0 | 1.3 | 0 | 0 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.0m | 1.3% | 6 | 0.0 | 1.5 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 1.5% | 5 | 0.0 | 1.2 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.0% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 0.1% | 5 | 0.0 | 0.9 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.0% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 0.3% | 4 | 0.0 | 0.9 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.1% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.0m | 0.6% | 3 | 0.0 | 0.8 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £5.0m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.1% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.0m | 0.2% | 3 | 0.0 | 0.8 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.0m | 0.3% | 3 | 0.0 | 0.8 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.5m | 2.4% | 3 | 0.0 | 0.5 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.2% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.5m | 0.2% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.5m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 0.3% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.0m | 0.8% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 1.8% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 1.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.5m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.0m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.9% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.4% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 0.7% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.9% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.0m | 1.4% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.0m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 11 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £6.5m | 1.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | COV (H) AVL (A) CHE (H) SUN (A) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £6.0m | 2.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BHA (A) ARS (H) HUL (A) NFO (H) | |
| £4.0m | 3.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £6.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) EVE (H) NEW (A) BRE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £6.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £5.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | TOT (H) LEE (A) SUN (H) BOU (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.0m | 5.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.0m | 2.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | AVL (H) CHE (A) LEE (H) COV (A) | |
| £5.5m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £6.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £5.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | FUL (A) BHA (H) ARS (A) HUL (H) | |
| £4.0m | 3.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 7.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 16.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.0m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.5m | 1.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | ARS (A) HUL (H) MCI (A) BHA (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £4.0m | 1.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | EVE (A) MCI (H) FUL (A) IPS (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £5.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CRY (H) BOU (A) MUN (H) TOT (A) | |
| £4.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | CHE (H) SUN (A) CRY (H) LIV (A) | |
| £4.0m | 2.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 2.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 1.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.5m | 2.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 2.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 1.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.0m | 2.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MUN (H) COV (A) AVL (H) CHE (A) | |
| £4.5m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 6.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 1.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 3.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 2.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 1.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.5m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | SUN (H) MUN (A) LIV (H) CRY (A) | |
| £5.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £4.5m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NFO (A) BRE (H) BHA (A) NEW (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 2.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £6.5m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) NFO (H) IPS (A) FUL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BOU (H) CRY (A) COV (H) MUN (A) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £7.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 1.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | HUL (A) IPS (H) EVE (A) MCI (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £6.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) TOT (A) BOU (H) LEE (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LEE (H) LIV (A) TOT (H) AVL (A) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (A) NEW (H) NFO (A) EVE (H) | |
| £4.0m | 1.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) | |
| £4.5m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | IPS (A) FUL (H) BRE (A) ARS (H) |